Manufacturer
14 recalls in our database name Actavis Elizabeth LLC as the manufacturing or recalling firm.
Of the 14 recalls from Actavis Elizabeth LLC we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 3 (21%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Actavis Elizabeth LLC is recalling Nifedipine Capsules USP, 10 mg, because the product may contain foreign tablets or capsules.
Actavis is recalling specific lots of amphetamine tablets because they failed impurity specifications. Consumers should stop using the product and contact their pharmacist.
Actavis Elizabeth LLC is recalling 257,746 bottles of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets, 20 mg, because they failed impurity specifications.
Actavis is recalling specific lots of 10 mg dextroamphetamine tablets because they failed impurity specifications. The recall covers 114,388 bottles distributed nationwide.
Actavis Elizabeth LLC is recalling 182,378 bottles of 30 mg Dextroamphetamine and Amphetamine tablets because they failed impurity specifications.
Actavis Elizabeth LLC is recalling 42 bottles of Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg, because they failed dissolution specifications.
Actavis Elizabeth LLC is recalling specific lots of Gabapentin 400 mg capsules distributed in Puerto Rico due to clumping, breaking, and packaging defects.
Actavis Elizabeth LLC is recalling GABA 300-EZS (Gabapentin) capsules distributed in Puerto Rico due to reports of clumping, breaking, and packaging defects.
Actavis Elizabeth LLC is recalling 29,622 bottles of Gabapentin capsules distributed in Puerto Rico due to clumping, breaking, and packaging defects.
Actavis Elizabeth LLC is recalling 9,447 bottles of Alprazolam 1 mg tablets because complaints reported significant tablet erosion.
Actavis Elizabeth LLC is recalling 5,148 bottles of Alprazolam Extended-Release Tablets, 3 mg, because the product failed to meet dissolution specifications.
Actavis Elizabeth LLC is recalling 13,608 bottles of Clonazepam 2 mg tablets because routine testing found one tablet with weight below specification.
Actavis Elizabeth LLC is recalling 756 bottles of Alprazolam 2 mg tablets because some tablets weighed less than the required specification.
Actavis Elizabeth LLC is recalling 9,264 bottles of amphetamine extended-release capsules because the product failed to meet dissolution specifications.